Current Medicare MIP measures encourage radiologists not to recommend follow-up for ≤ 1 cm adrenal nodules. However, a radiologist may be the first to discover a small, subclinical pheochromocytoma. As such, recognition of the enhancement pattern of pheochromocytoma is important to ensure detection and properly guide management, which begins with clinical and laboratory assessment for elevated catecholamines.
This is a preview of subscription content, log in to check access.
Compliance with ethical standards
Conflict of interest
Joseph Holman and Roberto Salvatori have nothing to disclosures. Elliot K. Fishman received grant funding from GE Healthcare and Siemens and Founder and stockholder of HipGraphics. Pamela T. Johnson is a Consultant to Oliver Wyman.
Mayo-Smith WW, Song JH, Boland GL, et al. (2017) Management of incidental adrenal masses: a white paper of the ACR incidental findings committee. J Am Coll Radiol. 14:1038–1044CrossRefGoogle Scholar
Oshmyansky AR, Mahammedi A, Dackiw A, et al. (2013) Serendipity in the diagnosis of pheochromocytoma. J Comput Assist Tomogr. 37(5):820–823CrossRefGoogle Scholar
Motta-Ramierz GA, Remer EM, Herts BR, Gill IS, Hamrahian AH (2005) Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. AJR 185:684CrossRefGoogle Scholar
Kopetschke R, Slisko M, Kilisli A, et al. (2009) Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. Eur J Endocrinol. 161(2):355–361CrossRefGoogle Scholar
Goldstein RE, O’Neill JA, Holcomb GW, et al. (1999) Clinical experience over 48 years with pheochromocytoma. Ann Surg. 229:755CrossRefGoogle Scholar
Northcutt BG, Raman S, Long CM, et al. (2013) MDCT of adrenal masses: can dual-phase enhancement patterns be used to distinguish between adenoma and pheochromocytoma. AJR 201:834–839CrossRefGoogle Scholar
Northcutt BG, Trakhtenbroit MA, Gomez EN, Fishman EK, Johnson PT (2016) Adrenal adenoma and pheochromocytoma: comparison of multidetector CT venous enhancement levels and washout characteristics. J Comput Assist Tomogr. 40:194–200CrossRefGoogle Scholar
Stamm M, Abele JT (2014) Streamlining the imaging of clinically suspected pheochromocytoma: using urine metanephrines to decrease imaging costs. Can Assoc Radiol J. 65:372–378CrossRefGoogle Scholar
Sawka AM, Jaeschke R, Singh RJ, Young WF Jr (2003) A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab. 88:553–558CrossRefGoogle Scholar